Poseida Therapeutics Receives US FDA Orphan Drug Destination for P-BCMA-101 for the Treatment of Multiple Myeloma by mparnell | May 13, 2019 | Portfolio News
Molecular Templates, Inc. Reports First Quarter 2019 Financial Results by mparnell | May 13, 2019 | Portfolio News
Kala Pharmaceuticals Reports First Quarter 2019 Financial Results by mparnell | May 9, 2019 | Portfolio News
Akebia Therapeutics Reports First Quarter 2019 Financial Results; Announces Full Enrollment of Phase 3 INNO2VATE Studies and Announces Key Executive Appointments by mparnell | May 9, 2019 | Portfolio News
Sublimity Therapeutics to Present Positive Data for Ulcerative Colitis Drug Candidate by mparnell | May 8, 2019 | Portfolio News
